Pacira Pharmaceuticals (PCRX - Get Report) is a specialty pharmaceutical company focused on the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. This stock is trading up 12% to $7.72 in recent trading.
Today's Range: $7.08-$7.8252-week Range: $6.16-$15.34 Volume: 2,043,000 Three-Month Average Volume: 168,986 This stock is spiking nicely today after the company announced the pricing of a public offering of 7 million shares of common stock at a price of $6.50 per share. >>10 Biotech Stocks Loved and Hated by the Pros From a technical standpoint, this stock is still trading well below its 50-day moving average of $9.23 despite the large move up today. Yes, volume is very strong, but that volume has much to do with the public offering. I would only consider getting interested in this stock from the long side if it can manage to move back above its 50-day moving average of $9.23 on high volume.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts